Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 6/20 | 0.45 |
| ▸ | FGFR2 | P21802 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4337068 | 0.84 | PAX3 (0.39) | GDAFGFR1FGFR2ALDH1A1ALOX15 | |
| SCHEMBL25324519 | 0.80 | RAB9A (0.51) | POLBKDM4ELMNAADORA3KMT2A | |
| SCHEMBL17260490 | 0.74 | POLB (0.35) | FGFR1FGFR2ALDH1A1ALOX15POLB | |
| SCHEMBL8781880 | 0.69 | CYP1A2 (0.40) | ALDH1A1POLBKDM4EADORA3KMT2A | |
| SCHEMBL7807597 | 0.68 | CYP1A2 (0.39) | ALDH1A1POLBADORA3KMT2A | |
| SCHEMBL24802600 | 0.67 | ADORA3 (0.56) | GDAFGFR1FGFR2ALDH1A1ALOX15 | |
| SCHEMBL16639430 | 0.65 | ADORA3 (0.54) | GDAFGFR1FGFR2ALDH1A1ALOX15 | |
| SCHEMBL219477 | 0.65 | GDA (0.62) | GDAFGFR1FGFR2ALDH1A1ALOX15 | |
| SCHEMBL29123832 | 0.65 | KDM4E (0.68) | GDAFGFR1FGFR2ALDH1A1ALOX15 | |
| SCHEMBL28520039 | 0.65 | DYRK1A (0.53) | GDAFGFR1FGFR2ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3143038-A1 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | Ugisense AG (DE) | 2017-03-22 | — | — | EP | claimed |
| WO-2015172889-A1 | PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS | UGICHEM GMBH (AT) | 2015-11-19 | — | — | WO | claimed |
| US-20230257413-A1 | ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF | RIKEN GENESIS CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-4219517-A1 | NOVEL ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF | Riken Genesis Co., Ltd. (JP) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023127857-A1 | NOVEL ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE OF SAME | 株式会社理研ジェネシス | 2023-07-06 | — | — | WO | disclosed |
| CN-116322706-A | Novel artificial nucleic acid, method for producing same, and use thereof | 株式会社理真思 | 2023-06-23 | — | — | CN | disclosed |
| CN-113646007-A | Novel artificial nucleic acid, method for producing same, and use thereof | 希森美康株式会社 | 2021-11-12 | — | — | CN | disclosed |
| CN-1045089-C | 2- (2-amino-1, 6-dihydro-6-oxo-purin-9-yl) methoxy-1, 3-propanediol derivatives | HOFFMANN LA ROCHE (CH) | 1999-09-15 | — | — | CN | disclosed |
| CN-1122804-A | 2- (2-amino-1, 6-dihydro-6-oxo-purin-9-yl) methoxy-1, 3-propanediol derivatives | HOFFMANN LA ROCHE (CH) | 1996-05-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230257413-A1 | ARTIFICIAL NUCLEIC ACID, METHOD FOR PRODUCING SAME, AND USE THEREOF | NSUN2, NSUN3, POLRMT | GDA 662/4885FGFR1 1100/4885FGFR2 1384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.